# An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes

> **NCT03216564** · PHASE3 · UNKNOWN · sponsor: **Hamad Medical Corporation** · enrollment: 320 (estimated)

## Conditions studied

- Diabetic Nephropathies

## Interventions

- **DRUG:** Calcitriol

## Key facts

- **NCT ID:** NCT03216564
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-10
- **Primary completion:** 2019-05-10
- **Final completion:** 2019-05-10
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2018-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03216564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03216564, "An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03216564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*